Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a small update to the page's metadata/presentation rather than any substantive study information.SummaryDifference0.0%

- Check14 days agoChange DetectedAdded explicit disease context by listing 'Multiple myeloma' and a related topics entry for MedlinePlus Genetics.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a bibliographic citation for the DREAMM-2 publication with full bibliographic details and identifiers, and updated the revision label to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now includes related topic links for Multiple Myeloma and MedlinePlus Genetics, linking the study to disease-specific resources.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page no longer shows the disease label 'Multiple myeloma' and the 'related topics' section that included MedlinePlus Genetics. This removes disease-specific context and a related informational resource from the study details page.SummaryDifference0.1%

- Check49 days agoChange DetectedUpdated the page’s footer/version marker to a newer release and added entries under the “related topics” section (e.g., MedlinePlus Genetics). This reflects supplementary site metadata/navigation rather than substantive changes to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.